Archives of Dermatology · 2001 · 54 citations · 2 references
MedicineClinical SciencesImmunologyCell TherapyImmunotherapyStem Cell TransplantationAutologous Stem Cell TransplantationSystemic SclerosisAutologous Stem Cell TherapyDermal Mucin DepositionFibroblast AbnormalitiesMelphalan ConditioningMucin ProductionMultiple TreatmentsPlasma Cell BiologyScleroderma Treatment
Seleromyxedema is characterized by dermal fibroblast proliferation and mucin deposition, associated with plasma cell dyscrasia. Therapy for systemic progression is often not effective, and the disease is potentially fatal. 1 We describe a man with rapidly progressive scleromyxedema in whom multiple treatments had failed before complete remission was achieved with treatment with high-dose pulse dexamethasone, high-dose melphalan, and autologous stem cell transplantation.
2